Company News for September 11, 2009 – Corporate Summary
Source: http://www.zacks.com/stock/news/24700/Company+News+for+September+11%2C+2009+-+Corporate+SummaryPosted on Friday, September 11th, 2009 | In Stocks to Watch
• Merck (NYSE:MRK) announced its plans to abandon an experimental treatment for migraines and to review Phase III clinical data on another migraine drug
• Morgan Stanley’s (NYSE:MS) CEO John Mack will be replaced before year-end by current co-president James Gorman
• Abbott Labs (NYSE:ABT) announced that it bought the 90% of Evalve that it does not already own for $410 million
• Bank of America (NYSE:BAC) cut its rating on Electronic Arts (NASDAQ:ERTS) to “neutral”
• Wells Fargo (NYSE:WFC) lowered its rating on AIG (NYSE:AIG) to “underperform” asserting the firm currently is trading “significantly” above book value
• National Semiconductor (NYSE:NSM) reported fiscal first quarter earnings of 13 cents a share, 6 cents above estimates on revenues of $314 million
Last 5 posts by Zacks Market Commentaries
- CNP & FPL Ink Pipeline Deal - Analyst Blog - November 20th, 2009
- Buffett Borrows for Rail Acquisition - Analyst Blog - November 20th, 2009
- Stone Energy Outdoes Estimates - Analyst Blog - November 20th, 2009
- Smucker's Beats, Raises Guidance - Analyst Blog - November 20th, 2009
- GameStop Meets Expectations - Analyst Blog - November 20th, 2009
Abbott Labs, Aig, Bank Of America, cent;, ceo, co-president, Electronic Arts, Evalve, James Gorman, John Mack, Merck, migraine, migraines;, Morgan Stanley, National Semiconductor;, Stocks to Watch, USD, wells fargo, Zacks Market Commentaries
![]() About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |



